Clinical Trials Browser

INDUSTRY × Interventional × Sexually Transmitted Diseases × Clear all

Sexually Transmitted Diseases, Papillomavirus Infections

NCT07281599 2026-02-02

EQUIP

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

NCT03981822 2024-11-27

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

NCT02482428 2021-01-05

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Phase 2 Completed

88 enrolled 10 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

NCT02724254 2018-07-20

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Phase 2 Completed

218 enrolled

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

NCT02535104 2018-06-06

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Phase 1/2 Completed

70 enrolled

Condylomata Acuminata, Sexually Transmitted Diseases, Papillomavirus Infections

Clinical Trials

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

EQUIP

CARE-1

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)